Bitcoin holds near support as mixed signals keep traders cautious
Bitcoin traded at $66,759 on March 29, 2026, holding within a tight 24-hour range between $66,266 and $67,185.

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Bitcoin traded at $66,759 on March 29, 2026, holding within a tight 24-hour range between $66,266 and $67,185.
FIN Resources (ASX:FIN) kicked off its maiden drilling program at the Cabin Lake Gold Project in Canada.
Spacetalk (ASX:SPA) secured firm commitments from institutional and professional investors to raise approximately $6 million.
Duratec (ASX:DUR) announced a milestone with the awarding of a multi-million-dollar service contract in Papua New Guinea.
Intercontinental Exchange has finalised a $600 million cash investment in Polymarket, completing the last stage of a structured funding plan announced in October 2025.
United-Guardian (NASDAQ:UG), a diversified manufacturer of pharmaceutical, cosmetic, and healthcare products, today reported its financial results for the full year ended December 31, 2025.
Satellos Bioscience (NASDAQ:MSLE), a biotechnology company focused on developing small-molecule therapies that modulate muscle stem cell regeneration, reported its full-year 2025 financial results and provided updates on recent corporate and clinical milestones.
LM Funding America (NASDAQ:LMFA), a cryptocurrency mining and specialty finance company, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
Novo Nordisk (NYSE:NVO) today announced that the U.S. Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae), the first and only once-weekly, long-acting basal insulin for adults living with type 2 diabetes.
Pharming Group (NASDAQ:PHAR), a global biopharmaceutical company dedicated to transforming the lives of patients with rare diseases, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion.